TransMedics Group Inc. (TMDX) at a glance
TransMedics Group Inc. (TMDX) is a mid-cap Healthcare company. It trades at $88.24, with a P/E of 22.9, a 22.7% profit margin and revenue growth of 20.7%. It does not pay a dividend. Vestovix scores it 39/100 overall. Its strongest dimension is Value (58/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.
- Price
- $88.24
- Market cap
- $3.07B
- P/E ratio
- 22.9
- Dividend yield
- None
- Beta
- 1.88
- 52-week range
- $60.11 to $156.00
Value
58
Growth
41
Income
40
Safety
12
Momentum
34
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,170.23-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$268.94+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$265.10-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$373.29-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$150.95-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.69+0.92%
2.16% yield
AMGN65
Amgen Inc.
$410.34-1.05%
2.76% yield